TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Infectious Disease
Division of General Internal Medicine
National Taiwan University Hospital Yunlin Branch
Division of General Internal Medicine
更新時間：2023-09-19
洪健清HUNG, CHIEN-CHING
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
85Publications
1
Huang, Y. S., Cheng, C. Y., Liou, B. H., Lu, P. L., Cheng, S. H., Lee, Y. T., . . . Taiwan, H. I. V. S. G. (2021). Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients. Jaids-Journal of Acquired Immune Deficiency Syndromes, 86(4), 473-481. doi:10.1097/qai.0000000000002589
2
Chen, G. J., Sun, H. Y., Chang, S. Y., Cheng, A., Huang, Y. S., Huang, S. H., . . . Hung, C. C. (2021). Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy. International Journal of Infectious Diseases, 105. doi:10.1016/j.ijid.2021.02.045
3
Hsiao, Y. Y., Huang, Y. C., Chang, S. Y., Kuo, C. H., Chang, S. F., Lin, Y. T., . . . Hung, C. C. (2021). Failure of pre-exposure prophylaxis with on-demand tenofovir disoproxil fumarate/emtricitabine resulting in emergence of antiretroviral resistance. Journal of Microbiology Immunology and Infection, 54(4), 755-757. doi:10.1016/j.jmii.2021.01.011
4
Liu, C. H., Chen, P. Y., Chen, J. J., Lo, C. C., Su, W. W., Tseng, K. C., . . . Kao, J. H. (2021). Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan. Hepatology International, 15(2), 338-349. doi:10.1007/s12072-021-10158-x
5
Liou, B. H., Sun, H. Y., Yang, C. J., Syue, L. S., Lee, Y. L., Tang, H. J., . . . Hung, C. C. (2021). Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study. Infectious Diseases and Therapy, 10(2), 827-838. doi:10.1007/s40121-021-00424-8
6
Liu, C. H., Sun, H. Y., Hsieh, S. M., Liu, W. C., Sheng, W. H., Liu, C. J., . . . Kao, J. H. (2021). Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy. Journal of Viral Hepatitis, 28(6), 887-896. doi:10.1111/jvh.13502
7
Lee YC, Liu WC, Hsieh YL, Wu CH, Wu PY, Luo YZ, Yang JY, Chen YH, Fang CT, Hung CC, Chang SC. Non-opioid recreational drug use and a prolonged HIV outbreak among men who have sex with men in Taiwan: An incident case-control study, 2006-2015. J Formos Med Assoc. 2021 Apr 3:S0929-6646(21)00120-0. doi: 10.1016/j.jfma.2021.03.015. Epub ahead of print. PMID: 33824010.
8
Lin, K. Y., Sun, H. Y., Chen, Y. H., Lo, Y. C., Hsieh, S. M., Sheng, W. H., . . . Chang, S. C. (2020). Effect of a Hepatitis A Vaccination Campaign During a Hepatitis A Outbreak in Taiwan, 2015-2017: A Modeling Study. Clinical Infectious Diseases, 70(8), 1742-1749. doi:10.1093/cid/ciz471
9
Ho, S. Y., Su, L. H., Sun, H. Y., Huang, Y. S., Chuang, Y. C., Huang, M. H., . . . Hung, C. C. (2020). Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011-2018. Eclinicalmedicine, 24. doi:10.1016/j.eclinm.2020.100441
10
Liu, C. H., Liu, C. J., Hung, C. C., Hsieh, S. M., Su, T. H., Sun, H. Y., . . . Kao, J. H. (2020). Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan. Liver International, 40(4), 758-768. doi:10.1111/liv.14295
